BPA Call 36C24820A0028-36C24823N0079
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract, valued at $810,091.80, was awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) under the VA's Veterans Integrated Service Network (VISN) 8. The contract is a BPA (Blanket Purchase Agreement) call against Biofire's General Services Administration (GSA) Federal Supply...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for $801,960.90 to provide "Molecular Pathogen Detection" services. The contract was awarded by the Veterans Health Administration (VHA), part of the Department of Veterans Affairs (VA), and is not set aside. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of MOLECULAR PATHOGEN DETECTION services. The $977,947.90 Firm Fixed Price contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its various Veterans Integrated Service Networks. The contract is a call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The award, valued at $1,598,542.00, is for molecular pathogen detection products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration...
- This is a federal contract award to Biofire Diagnostics LLC, a biotechnology company that specializes in syndromic infectious disease testing. The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), is for molecular pathogen detection services. The contract has a ceiling value of $513,156.00 and a period of performance through September 30, 2024. The contract was awarded against Biofire's existing General Services Administration (GSA) Federal...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $116,104.53, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for "MOLECULAR PATHOGEN DETECTION" services. It was awarded as a Blanket Purchase Agreement (BPA) call, a type of Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, against Biofire's existing General...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents and tests. The $430,808.73 ceiling value contract has a firm fixed price pricing type and was awarded by the...
- This federal contract award to Biofire Diagnostics LLC, a for-profit foreign-owned biotech company, is for "MOLECULAR PATHOGEN DETECTION" services. The contract is a Blanket Purchase Agreement (BPA) Call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a firm fixed price and a total ceiling value of $1,310,556.75. The award was made by the Department of Veterans Affairs (VA) Veterans...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $798,120.00, is for MOLECULAR PATHOGEN DETECTION services and was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) through its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $79,037.70, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide in-vitro reagents. The contract is a Blanket Purchase Agreement (BPA) call order under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797D30085-36C24820A0028Blanket Purchase Agreement
- 36C24820A0028-36C24823N0079BPA Call
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services at the Miami VA Medical Center (VAMC). The contract, valued at $556,524, was awarded on October 1, 2022 and has a completion date of September 30, 2023. The contract is a Blanket Purchase Agreement (BPA) Call placed against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. No set-aside designation was used. Biofire Diagnostics LLC has previously received numerous federal contract awards to provide a range of infectious disease testing products and services to agencies such as the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), the Defense Health Agency, the Department of Health and Human Services Indian Health Service, and the Department of State. The company also serves as a subcontractor for COVID-19 testing reproducibility studies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($113k) | 12/19/23 | |
| Not listed | Not listed | $669.6k | 10/1/22 |